MARKET

VYNE

VYNE

Vyne Therapeutics Inc
NASDAQ
0.6376
-0.0344
-5.12%
After Hours: 0.6305 -0.0071 -1.11% 19:45 07/10 EDT
OPEN
0.6251
PREV CLOSE
0.6720
HIGH
0.6581
LOW
0.6123
VOLUME
16.09M
TURNOVER
--
52 WEEK HIGH
1.595
52 WEEK LOW
0.2805
MARKET CAP
21.29M
P/E (TTM)
-1.2716
1D
5D
1M
3M
1Y
5Y
1D
VYNE declares special dividend ahead of Yarrow merger
TipRanks · 1d ago
VYNE Therapeutics declares special cash dividend with Yarrow Bioscience merger
TipRanks · 1d ago
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 1d ago
VYNE Therapeutics Announces Special Cash Dividend Of $0.38/Share
Benzinga · 1d ago
Vyne Therapeutics announces special shareholder meeting on proposed Yarrow merger
PUBT · 1d ago
*Vyne Therapeutics Will Pay Special Cash Div of $16.5M, or 38c Per Shr >VYNE
Dow Jones · 1d ago
VYNE THERAPEUTICS - SPECIAL CASH DIVIDEND ESTIMATED AT $16.5 MLN, OR $0.38 PER SHARE, RECORD DATE JULY 22, 2026
Reuters · 1d ago
Press Release: VYNE Therapeutics Declares Special Cash Dividend in Connection with the Proposed Merger with Yarrow Bioscience
Dow Jones · 1d ago
More
About VYNE
VYNE Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing differentiated therapies to treat chronic inflammatory and immune-mediated conditions with high unmet need. It is developing VYN202, an oral, small molecule BD2-selective BET inhibitor. VYN202 is an oral, small molecule BD2-selective BET inhibitor that has been designed to achieve potential class-leading potency and selectivity for BD2 vs. BD1. The Company has rights to research, develop and commercialize products containing BET inhibitor compounds for the treatment of any disease, disorder or condition in humans. Utilizing its InhiBET platform and through its preclinical and clinical activities, the Company is evaluating the impact that BET inhibitor compounds have on regulating.

Webull offers Vyne Therapeutics Inc stock information, including NASDAQ: VYNE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VYNE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VYNE stock methods without spending real money on the virtual paper trading platform.